Investigating the role of T-cell avidity and killing efficacy in relation to type 1 diabetes prediction

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Khadra, Anmar ^a   Pietropaolo, Massimo ^b   Nepom, Gerald T ^c   Sherman, Arthur ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELL KILLING; CELL MATURATION; CELL SPECIFICITY; CONTROLLED STUDY; DISEASE COURSE; INSULIN DEPENDENT DIABETES MELLITUS; MATHEMATICAL MODEL; MOLECULAR CLONING; PANCREAS ISLET BETA CELL; PREDICTION; RISK FACTOR; T LYMPHOCYTE ACTIVATION; HUMAN; IMMUNOLOGY; T LYMPHOCYTE; THEORETICAL MODEL;

DIABETES MELLITUS, TYPE 1; HUMANS; MODELS, THEORETICAL; T-LYMPHOCYTES;

EID: 79955883244     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014796     Document Type: Article

References (60)

1. Rossini AA, (2004) Autoimmune diabetes and the circle of tolerance. Diabetes 53: 267-275.
2. Seyfert-Margolis V, Gisler TD, Asare AL, Wang RS, Dosch HM, et al. (2006) Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study. Diabetes 55: 2588-2594.
3. Nepom GT, (2008) Approaching the Heisenberg principle of immunology. Clin Immunol 129: 1-2.
4. Homann D, Eisenbarth GS, (2006) An immunologic homunculus for type 1 diabetes. J Clin Invest 116: 1212-1215.
5. Winer S, Tsui H, Lau A, Song A, Li X, et al. (2003) Autoimmune islet destruction in spontaneous type 1 diabetes is not β-cell exclusive. Nat Med 9: 198-205.
6. Piganelli JD, Mathews CE, (2007) Autoreactive T-cell responses: new technology in pursuit of an old nemesis. Pediatr Diabetes 8: 249-251.
7. Cardozo AK, Ortis F, Storling J, Feng YM, Rasschaert J, et al. (2005) Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic β-cells. Diabetes 54: 452-461.
8. Kopito RR, Ron D, (2000) Conformational disease. Nat Cell Biol 2: E207-E209.
9. Estella E, McKenzie MD, Catterall T, Sutton VR, Bird PI, et al. (2006) Granzyme B-mediated death of pancreatic β-cells requires the proapoptotic BH3-only molecule bid. Diabetes 55: 2212-2219.
10. Homann D, Holz A, Bot A, Coon B, Wolfe T, et al. (1999) Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway. Immunity 11: 463-472.
11. Brusko TM, Putnam AL, Bluestone JA, (2008) Human regulatory T cells: role in autoimmune disease and therapeutic opportunities. Immunol Rev 223: 371-390.
12. Nelson P, Smith N, Ciupe S, Zou W, Omenn GS, et al. (2009) Modeling dynamic changes in type 1 diabetes progression: quantifying β-cell variation after the appearance of islet-specific autoimmune responses. Math Biosci Eng 6: 753-778.
13. Knip M, (2003) Environmental triggers and determinants of beta-cell autoimmunity and type 1 diabetes. Rev Endocr Metab Disord 3: 213-223.
14. Libman IM, Pietropaolo M, Arslanian SA, LaPorte RE, Becker DJ, (2003) Evidence for heterogeneous pathogenesis of insulin-treated diabetes in black and white children. Diabetes Care 26: 2876-2882.
15. Libman IM, Pietropaolo M, Arslanian SA, LaPorte RE, Becker DJ, (2003) Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes. Diabetes Care 26: 2871-2875.
16. Cretti A, Lehtovirta M, Bonora E, Brunato B, Zenti MG, et al. (2001) Assessment of β-cell function during the oral glucose tolerance test by a minimal model of insulin secretion. Eur J Clin Invest 31: 405-416.
17. Bergman RN, Zaccaro DJ, Watanabe RM, Haffner SM, Saad MF, et al. (2003) Minimal model-based insulin sensitivity has greater heritability and a different genetic basis than homeostasis model assessment or fasting insulin. Diabetes 52: 2168-2174.
18. Yoon JW, (1995) A new look at viruses in type 1 diabetes. Diabetes Metab Rev 11: 83-107.
19. Luppi P, Zanone MM, Hyoty H, Rudert WA, Haluszczak C, et al. (2000) Restricted TCR Vβ gene expression and enterovirus infection in type I diabetes: a pilot study. Diabetologia 43: 1484-1497.
20. Bingley PJ, (1996) Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study. Diabetes 45: 1720-1728.
21. Redondo MJ, Eisenbarth GS, (2002) Genetic control of autoimmunity in Type I diabetes and associated disorders. Diabetologia 45: 605-622.
22. Yamamoto AM, Deschamps I, Garchon HJ, Roussely H, Moreau N, et al. (1998) Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children. J Autoimmun 11: 643-650.
23. Pietropaolo M, Surhigh JM, Nelson PW, Eisenbarth GS, (2008) Primer: immunity and autoimmunity. Diabetes 57: 2872-2882.
24. Pietropaolo M, Becker DJ, LaPorte RE, Dorman JS, Riboni S, et al. (2002) Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes. Diabetologia 45: 66-76.
25. Morran MP, Omenn GS, Pietropaolo M, (2008) Immunology and genetics of type 1 diabetes. Mt Sinai J Med 75: 314-327.
26. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, et al. (1996) Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45: 926-933.
27. Pietropaolo M, Peakman M, Pietropaolo SL, Zanone MM, Foley TP Jr, et al. (1998) Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus. J Autoimmun 11: 1-10.
28. Rewers M, Bugawan TL, Norris JM, Blair A, Beaty B, et al. (1996) Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia 39: 807-812.
29. Maclaren N, Lan M, Coutant R, Schatz D, Silverstein J, et al. (1999) Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2β predict immune-mediated (type 1) diabetes in relatives. J Autoimmun 12: 279-287.
30. Bluestone JA, Herold K, Eisenbarth G, (2010) Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464: 1293-1300.
31. Pietropaolo M, Eisenbarth GS, (2001) Autoantibodies in human diabetes. Curr Dir Autoimmun 4: 252-282.
32. Pietropaolo M, Barinas-Mitchell E, Kuller LH, (2007) The heterogeneity of diabetes: unraveling a dispute: is systemic inflammation related to islet autoimmunity? Diabetes 56: 1189-1197.
33. Morran MP, Casu A, Arena VC, Pietropaolo S, Zhang YJ, et al. (2010) Humoral autoimmunity against the extracellular domain of the neuroendocrine autoantigen IA-2 heightens the risk of type 1 diabetes. Endocrinology 151: 2528-2537.
34. Khadra A, Tsai S, Santamaria P, Edelstein-Keshet L, (2010) On how monospecific memory-like autoregulatory CD8+ T cells can blunt diabetogenic autoimmunity: a computational approach, J Immunol 185: 5962-5972.
35. Khadra A, Santamaria P, Edelstein-Keshet L, (2009) The role of low avidity T cells in the protection against type 1 diabetes: A modeling investigation. J Theor Biol 256: 126-141.
36. Khadra A, Santamaria P, Edelstein-Keshet L, (2010) The pathogenicity of self-antigen decreases at high levels of autoantigenicity: a computational approach. Int Immunol 22: 571-582.
37. Shannon M, Mehr R, (1999) Reconciling repertoire shift with affinity maturation: The role of deleterious mutations. J Immunol 162: 3950-3956.
38. Shahaf G, Barak M, Zuckerman NS, Swerdlin N, Gorfine M, (2008) Antigen-driven selection in germinal centers as reflected by the shape characteristics of immunoglobulin gene lineage trees: A large-scale simulation study. J Theor Biol 255: 210-222.
39. Head M, Meryhew N, Runquist O, (1996) Mechanism and computer simulation of immune complex formation, opsonization, and clearance. J Lab Clin Med 128: 61-74.
40. Finegood DT, Scaglia L, Bonner-Weir S, (1995) Dynamics of β-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 44: 249-256.
41. Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, Becker DJ, Gitelman SE, et al. (2009) Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 361: 2143-2152.
42. Standifer NE, Burwell EA, Gersuk VH, Greenbaum CJ, Nepom GT, (2009) Changes in autoreactive T cell avidity during type 1 diabetes development. Clin Immunol 132: 312-320.
43. Skowera A, Ellis RJ, Varela-Calviño R, Arif S, Huang GC, et al. (2008) CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J Clin Invest 118: 3390-3402.
44. Mahaffy JM, Edelstein-Keshet L, (2007) Modeling cyclic waves of circulating T-cells in autoimmune diabetes. SIAM J Applied Math (SIAP) 67: 915-937.
45. Vendrame F, Pileggi A, Laughlin E, Allende G, Martin-Pagola A, et al. (2010) Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes 59: 947-957.
46. Durinovic-Belló I, Wu RP, Gersuk VH, Sanda S, Shilling HG, et al. (2010) Insulin gene VNTR genotype associates with frequency and phenotype of the autoimmune response to proinsulin. Genes Immun 11: 188-193.
47. Kurrer MO, Pakala SV, Hanson HL, Katz JD, (1997) β cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci USA 94: 213-218.
48. Shochat E, Rom-Kedar V, Segel LA, (2007) G-CSF control of neutrophils dynamics in the blood. Bull Math Biol 69: 2299-2338.
49. Mallone R, Kochik SA, Reijonen H, Carson B, Ziegler SF, et al. (2005) Functional avidity directs T-cell fate in autoreactive CD4+ T cells. Blood 106: 2798-2805.
50. Miao D, Yu L, Eisenbarth GS, (2007) Role of autoantibodies in type 1 diabetes. Front Biosci 12: 1889-1898.
51. Reijonen H, Mallone R, Heninger AK, Laughlin EM, Kochik SA, et al. (2004) GAD65-specific CD4+ T-cells with high antigen avidity are prevalent in peripheral blood of patients with type 1 diabetes. Diabetes 53: 1987-1994.
52. Tsai S, Shameli A, Yamanouchi J, Clemente-Casares X, Wang J, et al. (2010) Reversal of autoimmunity by boosting memory-like autoregulatory T-cells. Immunity 32: 568-580.
53. De Boer RJ, Perelson AS, (1994) T cell repertoires and competitive exclusion. J Theor Biol 169: 375-390.
54. Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, et al. (1994) Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43: 1304-1310.
55. Pietropaolo M, Yu S, Libman IM, Pietropaolo SL, Riley K, et al. (2005) Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies. Pediatr Diabetes 6: 184-192.
56. Nepom GT, Lippolis JD, White FM, Masewicz S, Marto JA, et al. (2001) Identification and modulation of a naturally processed T cell epitope from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65). Proc Natl Acad Sci USA 98: 1763-1768.
57. Marino S, Hoguea IB, Raya CJ, Kirschner DE, (2008) A methodology for performing global uncertainty and sensitivity analysis in systems biology. J Theor Biol 254: 178-196.
58. Vernino L, McAnally LM, Ramberg J, Lipsky PE, (1992) Generation of nondividing high rate Ig-secreting plasma cells in cultures of human B cells stimulated with anti-CD3-activated T cells. J Immunol 148: 404-410.
59. Parham P, (2009) The immune system", 3rd edition, Garland Science, Taylor & Francis Group, LLC.
60. Kim P, Lee P, Levy D, (2007) Modeling regulation mechanisms in the immune system. J Theor Biol 246: 33-69.